Vaccinex Inc News - VCNX

Professional-Grade Tools, for Individual Investors.

Premium

Form 8-K - Current report

Vaccinex Announces Receipt of Delisting Notification from Nasdaq

ROCHESTER, N.Y., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX) (“Vaccinex” or the...

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Vaccinex Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Actively Exploring Partnership for Alzheimer’s DevelopmentSupplementary Financing Concluded in Q4 ROCHESTER...

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Vaccinex Provides Update on ActivMAb® Platform: Multiple Project Deals and Presentation at SITC

ROCHESTER, N.Y., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage...

Vaccinex Reports Improved Immunity Correlating with Clinical Benefit of Pepinemab Combination Treatment at Society for Immunotherapy of Cancer’s Annual Meeting

ROCHESTER, N.Y., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage...

Vaccinex Reports New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab at Clinical Trials on Alzheimer’s Disease (CTAD) Conference in Madrid, Spain

ROCHESTER, N.Y., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Vaccinex (Nasdaq: VCNX) today provided an update on new...

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form EFFECT - Notice of Effectiveness

Vaccinex to Report Promising New Efficacy Data for SIGNAL-AD Phase 1b/2 trial of Pepinemab at Clinical Trials on Alzheimer’s Disease (CTAD) Conference on October 31, 2024

ROCHESTER, N.Y., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage...

dinogreeves 7 days ago

I really don't know what these guys tried to accomplish.

👍️0

eur06 7 days ago

Down to . 85 does all this make sense to you dino?
I'm tempted to add more but at this pps bids are not filled and low volume means insiders still holding.

PonkenPlonken 1 week ago

Low float scheme gets delisted to "shake out" retail traders.
Thats a first for me.

👍️0

PonkenPlonken 1 week ago

Zauderer secured a lavish lifestyle for himself with this.
The question is at which point in time did he get a hunch pepinemab doesnt have the therapeutic value he promised?
So instead of telling patients to seek proper medication - he milked the shareholders - on the back of the patients - for years.

👍️0

Renee 1 week ago

VCNX delisted from the Nasdaq to the OTC. **stock dropped 62% from $3.65 to $1.40.

https://otce.finra.org/otce/dailyList?viewType=Additions

👍️ 1

tw0122 1 week ago

Loaded more in $1.30s hopefully temp bottom. Trading shows perhaps most retail out not entire float trades on beat down

👍️0

dinogreeves 1 week ago

Who knows, maybe they did this to get retail out as much they can, that is why I held half.

👍️0

eur06 1 week ago

I almost feel bad for that insider that bought 1M at $4….we’ll see.
VCNX

👍️0

eur06 1 week ago

Good to know dino…thanks!!
VCNX

👍️0

dinogreeves 1 week ago

I took a big hit this morning euro, sold half and keeping the rest waiting for a dip after delisting day. Fortunately for me, I scored great on TNXP from 28 cents all the way to 1.39.

👍️0

eur06 1 week ago

Oops…..1.35…hopefully buying now is a good choice!!
VCNX

👍️0

tw0122 1 week ago

Absolutely correct just picked up $1.50s on non compliance news. We all know they will eventually become compliant again. Nice day for shorts here.

👍️0

dinogreeves 1 week ago

One thing everyone needs to understand is that until this ticker gains compliance, it is unlikely to rise above $4, and certainly not over $5. Market makers are fully aware of the lack of compliance and are keeping a tight control over the stock. They know that retail investors will become impatient and may sell into the bid. Bullish on all fronts, this is something you have to buy the dip and hold for the purest Gold, this doesn't get any better. It could be a buyout, it could be massive partnership. Either or once the news is announced, guaranteed it will open with only 1 share at that price, you wont have an opportunity to get in. I am very confident something big is coming.

Currently, none-compliant tickers tend to remain in limbo. Once compliance is achieved, market makers will likely adjust their strategies, potentially driving the price up by 30-50% before any official news from the company is released. For now, these prices represent a unique opportunity. I am bullish on all fronts, there are no flaws with this ticker, other than the fact that the impatient are selling into the bid due to market maker manipulation. Just sit tight this is going to do wonders.

In due time, I believe we could see the market cap reach $250 million as a starting point. This figure does not even account for a complete sale of the company, which could range from $500 million to $1 billion. However, I anticipate that this won’t occur for at least another two weeks.

👍️0

dinogreeves 1 week ago

Just a little longer, looks like a couple of people are getting a little impatient with VCNX on Stocktwits board, Vinnie did a nice write up for the board so people can read. This is going to flounder this range until compliant from Nasdaq then official news from the company, then the obvious boom town. Market makers have a close grip on this thing, they know they are not compliant yet, once they are in compliant market makers will quickly adjust and we will get over $4.00 most definitely and aim for $5 until news. I will be buying again in this range sometime this week or next week, want to make sure I buy a good load.

👍️0

dinogreeves 2 weeks ago

I don't know who sold below 3.80 on Friday, bought more, buying more next week. This is going to boom, only a few days left for Nasdaq compliant then news thus all hell will break loose.

👍️0

eur06 2 weeks ago

Very happy for you dino.
I’m waiting for new funds but satisfied with what I have already.
VCNX

👍️0

vinnie1965 2 weeks ago

What would the price be if we had a 3 Billion buyout...

👍️0

vinnie1965 2 weeks ago

For now anything in this range gobble them up For now anything in this range gobble them up

👍️0

dinogreeves 2 weeks ago

bought another 420 shares this morning, I will keep buying, have another 1500 shares to go for 10,000 shares total. If the price stays this range before the complaint from Nasdaq is released, might be able to get another 2000-3000 shares in addition to my 10,000 shares, before all hell breaks loose here with this one. Alzheimers data comes, easy 500 million market cap in a blink, especially with partnership announcements. No brainer on all fronts.

👍️0

vinnie1965 2 weeks ago

So another week or two before Nasdaq complaint news hits the wires
For now anything in this range gobble them up

👍️0

vinnie1965 2 weeks ago

No news and nothing will happen until they are compliant with NASDAQ, then we will get news

👍️0

eur06 2 weeks ago

I'm envious I did not🙃 lol

👍️0

dinogreeves 2 weeks ago

Added another 860 shares today. 2000 more shares to go to round it up to 10,000 shares. The new DD is outstanding.

👍️0

eur06 2 weeks ago

I’m copying you dino.
We might get some good news this week !!!
VCNX

👍️0

dinogreeves 2 weeks ago

It will so fast and furious, market makers will not be able to contain it.

👍️0

dinogreeves 2 weeks ago

This is going to go BOOM, soon, very soon.

👍️0

dinogreeves 2 weeks ago

Of course they are. Not one bit concerned. The more they keep this one down here, the more I will buy.

👍️0

eur06 2 weeks ago

Lol they are working overtime to keep it under 3.80 !!!
Ok then.

👍️0

eur06 2 weeks ago

Great stuff dino.
VCNX

👍️0

dinogreeves 2 weeks ago

Bought another 1151 shares this morning.

👍️0

frans 3 weeks ago

I am in for long hold no problem thank you and nice weekend

👍️0

dinogreeves 3 weeks ago

frans, this is a hold for dear life. One morning you will wake up and see this at minimum 250 million market cap as a starter.

👍️0

tw0122 3 weeks ago

Nice low floater held support🚀

👍️0

eur06 3 weeks ago

I agree dino, regardless of this type of price action it’s a buy for me also.
VCNX

👍️0

dinogreeves 3 weeks ago

I am not going to dwell over the daily price action, I am going to add more tomorrow.

👍️0

frans 3 weeks ago

an verry long time at this prices - show not good

👍️0

dinogreeves 3 weeks ago

I don't about news on the horizon. This is hold and buy the dip anything under 4 dollars. Patience.

👍️0

frans 3 weeks ago

they dump hard - no news on the horizon ????

👍️0

dinogreeves 3 weeks ago

I will be quietly loading again this week, anything under 4.

👍 1 🚀 1

dinogreeves 3 weeks ago

This goes below 4 again, I will buy another 1000 shares hand over fist.

👍️0

frans 3 weeks ago

e: None

Monday, December 02, 2024 4:03:34 PM

Post#
256
of 263
Vaccinex (VCNX) 11/7 $4.13 + 9% announced the signing of several proprietary project agreements with Amgen (AMGN), Merck (MRK), Chugai, Absci (ABSI), Gigagen (Grifols), Merus (MRUS), Soleil, ThirdArc and Incyte (INCY), employing Vaccinex's ActivMAb technology to generate antibodies to complex antigen targets. In addition, Vaccinex has signed agreements to provide Charles River Labs, OmniAb, Adimab and other undisclosed strategic partners with materials to facilitate their antibody discovery programs using transgenic animal species for immunization or very large synthetic antibody libraries. The financial terms of the agreements are undisclosed.

👍️ 1

dinogreeves 3 weeks ago

Valuation could reach 100 million and still be cheap, way cheap.

👍️0

dinogreeves 3 weeks ago

Can't stop thinking about this one. "You are always on my Mind"

👍️0

dinogreeves 3 weeks ago

Going to pop big.

👍️0

dinogreeves 3 weeks ago

VCNX is going to shock the market.

👍️0

tw0122 3 weeks ago

Looking good in this one

👍️0

dinogreeves 3 weeks ago

Trading beautifully. Double digits in sight without a doubt.

👍️0

dinogreeves 3 weeks ago

Probably because they are not compliant yet, they have a meeting with Nasdaq on the 5th. E Trade is the best platform by far. Once they are in compliant this will run, plus their patent just got approved but they haven't released the news yet.

👍️0

tw0122 3 weeks ago

Vaccinex (VCNX) 11/7 $4.13 + 9% announced the signing of several proprietary project agreements with Amgen (AMGN), Merck (MRK), Chugai, Absci (ABSI), Gigagen (Grifols), Merus (MRUS), Soleil, ThirdArc and Incyte (INCY), employing Vaccinex's ActivMAb technology to generate antibodies to complex antigen targets. In addition, Vaccinex has signed agreements to provide Charles River Labs, OmniAb, Adimab and other undisclosed strategic partners with materials to facilitate their antibody discovery programs using transgenic animal species for immunization or very large synthetic antibody libraries. The financial terms of the agreements are undisclosed.

👍️0

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Vaccinex Inc (VCNX)

Professional-Grade Tools, for Individual Investors.

VCNX News

Form 8-K - Current report

Vaccinex Announces Receipt of Delisting Notification from Nasdaq

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Vaccinex Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Vaccinex Provides Update on ActivMAb® Platform: Multiple Project Deals and Presentation at SITC

Vaccinex Reports Improved Immunity Correlating with Clinical Benefit of Pepinemab Combination Treatment at Society for Immunotherapy of Cancer’s Annual Meeting

Vaccinex Reports New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab at Clinical Trials on Alzheimer’s Disease (CTAD) Conference in Madrid, Spain

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form EFFECT - Notice of Effectiveness

Vaccinex to Report Promising New Efficacy Data for SIGNAL-AD Phase 1b/2 trial of Pepinemab at Clinical Trials on Alzheimer’s Disease (CTAD) Conference on October 31, 2024

VCNX Discussion

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Vaccinex Inc (VCNX) News

Vaccinex Inc (VCNX)

Professional-Grade Tools, for Individual Investors.

VCNX News

Form 8-K - Current report

Vaccinex Announces Receipt of Delisting Notification from Nasdaq

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Vaccinex Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Vaccinex Provides Update on ActivMAb® Platform: Multiple Project Deals and Presentation at SITC

Vaccinex Reports Improved Immunity Correlating with Clinical Benefit of Pepinemab Combination Treatment at Society for Immunotherapy of Cancer’s Annual Meeting

Vaccinex Reports New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab at Clinical Trials on Alzheimer’s Disease (CTAD) Conference in Madrid, Spain

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form EFFECT - Notice of Effectiveness

Vaccinex to Report Promising New Efficacy Data for SIGNAL-AD Phase 1b/2 trial of Pepinemab at Clinical Trials on Alzheimer’s Disease (CTAD) Conference on October 31, 2024

VCNX Discussion

Your Recent History

Company

Business

Popular

Get The App

Go Ad-Free